Literature DB >> 10553804

Safety and efficacy study with various doses of SS-cream in patients with premature ejaculation in a double-blind, randomized, placebo controlled clinical study.

H K Choi1, Z C Xin, Y D Choi, W H Lee, S Y Mah, D K Kim.   

Abstract

OBJECTIVES: SS-cream is a topical agent made from the extracts of natural products for treating premature ejaculation (PE). To determine the optimal clinical dosage of SS-cream on PE, we investigated the safety and efficacy of SS-cream with various doses. A double blind, randomized placebo controlled clinical study was performed.
METHODS: Fifty patients completed the study. Mean age of the patients was 37.1+/-1.O y and mean ejaculatory latency was 1.35+/-0.07 min. Sexual satisfaction rate of both the partner and patient was 16.2%. Each patient was instructed to apply the different cream (placebo, SS-cream 0.05, 0.10, 0.15, 0.20 g) on glans penis 1 h before sexual intercourse in random fashion. The ejaculatory latency was measured by stop watch and the satisfaction rate of both partner and patient was also recorded two times in the screening period and after the application of each test drugs. Clinical efficacy was considered if ejaculatory latency was prolonged more than 2 min and sexual satisfaction rate increased more than 20% than that of pretest values.
RESULTS: The mean ejaculatory latencies were significantly prolonged after using various test drugs (placebo 2.27+/-0.32, SS-cream 0.05 g 4.47+/-0.81, 0.10 g 5.34+/-0.79, 0.15 g 6.22+/-0.87, 0.20 g 11.06+/-1.17 min, respectively). Clinical efficacies evaluated by ejaculatory latency were placebo 18%, SS-cream 0.05 g 30%, 0.10 g 60%, 0.15 g 54%, 0.20 g 84%, respectively. The satisfaction rate was also significantly increased dose-dependently (placebo 26%, SS-cream 0.05 g 60%, 0.10 g 70%, 0.15 g 78%, 0.20 g 90%, respectively). A side effect such as local mild burning sensation was noted in 35/250 times (14%) and no adverse effect on sexual function and no systemic side effects were observed. From the result of logistic regression analysis on clinical efficacy, the ED50 of SS-cream was obtained as 0.10 g. SS-cream 0.20 g was effective in 84% without any serious systemic side effects.
CONCLUSION: From the above results, our conclusions are that SS-cream is effective on the treatment of PE with a few local side effects and that clinical optimal dose of SS-cream is 0.20 g.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10553804     DOI: 10.1038/sj.ijir.3900431

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN: 0955-9930            Impact factor:   2.896


  11 in total

1.  Prevalence of premature ejaculation in young and middle-aged men in Korea: a multicenter internet-based survey from the Korean Andrological Society.

Authors:  Hyun Jun Park; Jong Kwan Park; Kwangsung Park; Sung Won Lee; Sae-Woong Kim; Dae Yul Yang; Du Geon Moon; Kweon-Sik Min; Ki-Hak Moon; Sang-Kuk Yang; Jae Seog Hyun; Nam Cheol Park
Journal:  Asian J Androl       Date:  2010-08-02       Impact factor: 3.285

2.  Men's aging and sexual disorders: an update on diagnosis and treatment.

Authors:  Alvaro Morales
Journal:  Rev Endocr Metab Disord       Date:  2005-05       Impact factor: 6.514

3.  Premature ejaculation: prevalent but poorly understood.

Authors:  J Rajfer
Journal:  Rev Urol       Date:  2000

Review 4.  Panax ginseng: a systematic review of adverse effects and drug interactions.

Authors:  Joanna Thompson Coon; Edzard Ernst
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

5.  Pharmacotherapy of sexual dysfunctions : current status.

Authors:  Ajith Avasthi; Parthasarathy Biswas
Journal:  Indian J Psychiatry       Date:  2004-07       Impact factor: 1.759

Review 6.  Efficacy and safety of local anaesthetics for premature ejaculation: a systematic review and meta-analysis.

Authors:  Jia-Dong Xia; You-Feng Han; Liu-Hua Zhou; Yun Chen; Yu-Tian Dai
Journal:  Asian J Androl       Date:  2013-05-27       Impact factor: 3.285

Review 7.  Disorders of ejaculation.

Authors:  E A Jannini; C Simonelli; A Lenzi
Journal:  J Endocrinol Invest       Date:  2002-12       Impact factor: 4.256

8.  Safety and efficacy of tramadol hydrochloride on treatment of premature ejaculation.

Authors:  Bayoumy I Eassa; Mohamed A El-Shazly
Journal:  Asian J Androl       Date:  2012-10-29       Impact factor: 3.285

9.  Emerging treatments for premature ejaculation: focus on dapoxetine.

Authors:  Wayne J G Hellstrom
Journal:  Neuropsychiatr Dis Treat       Date:  2009-04-08       Impact factor: 2.570

Review 10.  Conversations in the operating room: history of the development of a promising new compound for the treatment of premature ejaculation.

Authors:  Alvaro Morales
Journal:  Transl Androl Urol       Date:  2012-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.